Author Archives: nkf _advocacy

About nkf _advocacy

The National Kidney Foundation's advocacy movement is for all people affected by CKD, transplant candidates and recipients, living and potential donors, donor families and caregivers. We empower, educate and encourage you to get involved on issues relating to CKD, donation and transplantation.

The Trump Administration Will Know that CKD is a Public Health Priority

By Tonya L. Saffer, MPH Fueled by passion and urgency your government relations team is dedicated to ensuring that the Trump Administration recognizes chronic kidney disease as a public health priority. Along with NKF’s Executive Leadership, we will be working … Continue reading

Posted in Uncategorized | 2 Comments

The Affordable Care Act’s future and the impact on people with kidney disease

By Troy Zimmerman, National Kidney Foundation’s Vice President of Government Relations The Affordable Care Act (ACA), also known as Obama Care, passed in 2010 and was intended to allow more Americans to access affordable and comprehensive health insurance coverage.  This … Continue reading

Posted in Uncategorized | 4 Comments

National Kidney Foundation Advocacy Priorities for 2017

By Troy Zimmerman We ended 2016 with many legislative and administrative successes to improve the lives of kidney patients, but also continue to face great challenges. With the introduction of a new Congress and a new Administration there remains much … Continue reading

Posted in Uncategorized | 1 Comment

Kidney Advocacy Victories in 2016

Advocating relentlessly on behalf of kidney patients the National Kidney Foundation (NKF) is proud of the accomplishments we have achieved in advancing policy solutions that benefit people with kidney disease.   Our success would not be possible without you, so as … Continue reading

Posted in Uncategorized | 3 Comments

Congress passes the 21st Century Cures Act

The National Kidney Foundation (NKF) congratulates Congress on passing H.R. 34, the 21st Century Cures Act.  Passing the House and Senate by overwhelming votes, this legislation makes significant reforms and investments in health care. For kidney disease patients, this legislation … Continue reading

Posted in Uncategorized | 3 Comments

Idaho Takes a Leading Role on Medigap Reform

Exciting news for kidney disease patients in Idaho to be thankful for this holiday season! Idaho released its final reforms on Medigap insurance, which will make large strides towards helping give end stage renal disease patients (ESRD) under age 65 new … Continue reading

Posted in Uncategorized | 1 Comment

A Historic Election

The presidential election was historic in many regards, including the first woman as a major party nominee and a nominee with no previous public office or military experience.  The Republican party will now have control of the White House, both … Continue reading

Posted in Uncategorized | 3 Comments

Organ recipients share their experiences with FDA to promote innovation in immunosuppressive therapies

By Kevin Longino, CEO and Leilah Sampson, Kidney Advocacy Committee Patient Liaison As kidney transplant recipients and advocates we were enthusiastic and hopeful to learn that the Food and Drug Administration (FDA) had scheduled a public meeting for organ transplant … Continue reading

Posted in Uncategorized | 8 Comments

Ask your U.S. Representatives to co-sponsor the immunosuppressive drug coverage extension!

On September 22nd, Representatives Burgess (R-TX), Kind (D-WI), Harper (R-MI), Meehan (R-PA), Herrera Beutler (R-WA), Cooper (D-TN), Griffith (R-VA), and McDermott (D-WA) introduced the Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act (H.R. 6139).  These sponsors seek to provide … Continue reading

Posted in Uncategorized | 2 Comments

The ESRD Choice Act of 2016 Passes the House

On September 21, 2016, the House of Representatives unanimously passed H.R. 5659, the Expanding Seniors Receiving Dialysis Choice Act or ESRD Choice Act.  The 423-0 vote included 242 Republicans and 181 Democrats. This is a victory for kidney disease patients.  … Continue reading

Posted in Uncategorized | 1 Comment